New COPD inhaler shows promise in early trial
NCT ID NCT06545500
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an inhaled medication called glycopyrrolate in 46 people with COPD. Participants received three different doses of the drug and a placebo over separate one-week periods. The goal was to see if the drug improves lung function and is safe. This is an early-stage trial to find the right dose for future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
American Health Research Inc
Charlotte, North Carolina, 28277, United States
-
Clinical Research of West Florida Inc - Clearwater
Clearwater, Florida, 33765, United States
-
Clinical Research of West Florida Inc - Tampa
Tampa, Florida, 33606, United States
-
Midwest Chest Consultants PC
Saint Charles, Missouri, 63301, United States
-
Velocity Clinical Research - Greenville
Greenville, South Carolina, 29615, United States
-
Velocity Clinical Research - Spartanburg
Spartanburg, South Carolina, 29303, United States
-
Velocity Clinical Research - Union
Union, South Carolina, 29379, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart breathing machines at home: a new way to predict COPD crises?
- Breathing easy? new X-Ray method may spot COPD decline early
- Could a common heart drug cut COPD hospitalizations?
- Which inhaler breathes better? a Head-to-Head COPD showdown
- Could tiny lung valves revive heart and muscle strength in COPD?
- One lung or two? surgery trial aims to find the best approach for severe COPD